BMRN
Price
$57.32
Change
-$0.29 (-0.50%)
Updated
Feb 4, 02:26 PM (EDT)
Capitalization
11.07B
21 days until earnings call
Intraday BUY SELL Signals
LTRN
Price
$2.97
Change
-$0.09 (-2.94%)
Updated
Feb 4, 02:58 PM (EDT)
Capitalization
33.44M
29 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRN vs LTRN

Header iconBMRN vs LTRN Comparison
Open Charts BMRN vs LTRNBanner chart's image
BioMarin Pharmaceutical
Price$57.32
Change-$0.29 (-0.50%)
Volume$170
Capitalization11.07B
Lantern Pharma
Price$2.97
Change-$0.09 (-2.94%)
Volume$239
Capitalization33.44M
BMRN vs LTRN Comparison Chart in %
BMRN
Daily Signal:
Gain/Loss:
LTRN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMRN vs. LTRN commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and LTRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BMRN: $57.61 vs. LTRN: $3.06)
Brand notoriety: BMRN and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 66% vs. LTRN: 116%
Market capitalization -- BMRN: $11.07B vs. LTRN: $33.44M
BMRN [@Biotechnology] is valued at $11.07B. LTRN’s [@Biotechnology] market capitalization is $33.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, LTRN is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while LTRN’s TA Score has 2 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 2 bearish.
  • LTRN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than LTRN.

Price Growth

BMRN (@Biotechnology) experienced а +1.34% price change this week, while LTRN (@Biotechnology) price change was -7.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 25, 2026.

LTRN is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($11.1B) has a higher market cap than LTRN($33.4M). LTRN YTD gains are higher at: 0.990 vs. BMRN (-3.062). BMRN has higher annual earnings (EBITDA): 772M vs. LTRN (-19.65M). BMRN has more cash in the bank: 1.48B vs. LTRN (12.4M). LTRN has less debt than BMRN: LTRN (94K) vs BMRN (604M). BMRN has higher revenues than LTRN: BMRN (3.09B) vs LTRN (0).
BMRNLTRNBMRN / LTRN
Capitalization11.1B33.4M33,234%
EBITDA772M-19.65M-3,928%
Gain YTD-3.0620.990-309%
P/E Ratio21.42N/A-
Revenue3.09B0-
Total Cash1.48B12.4M11,919%
Total Debt604M94K642,553%
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
73
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNLTRN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
59%
N/A
Declines
ODDS (%)
Bearish Trend 20 days ago
62%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signal:
Gain/Loss:
LTRN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BLDG25.430.07
+0.29%
Cambria Global Real Estate ETF
NEWTZ24.98N/A
N/A
NewtekOne
IJUN29.97-0.01
-0.02%
Innovator Intl Dev Pwr Bffr ETF - Jun
SHYL44.89-0.03
-0.08%
Xtrackers Short Duration High Yld Bd ETF
DDWM45.58-0.07
-0.15%
WisdomTree Dynamic International Eq ETF

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with FOLD. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then FOLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.59%
FOLD - BMRN
58%
Loosely correlated
-0.07%
TECH - BMRN
48%
Loosely correlated
-0.95%
BEAM - BMRN
44%
Loosely correlated
-0.11%
ARQT - BMRN
43%
Loosely correlated
+2.42%
ORKA - BMRN
43%
Loosely correlated
+0.73%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
N/A
AXON - LTRN
36%
Loosely correlated
-1.89%
ARWR - LTRN
34%
Loosely correlated
-1.18%
RLAY - LTRN
33%
Poorly correlated
+6.38%
BMRN - LTRN
33%
Poorly correlated
-0.59%
BCYC - LTRN
32%
Poorly correlated
-7.55%
More